Merck KGaA (MRK):企業の財務・戦略的SWOT分析

◆英語タイトル:Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1667
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:82
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Merck KGaA (MRK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Merck KGaA (Merck), a subsidiary of E. Merck KG, is a science and technology company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis and infertility; and develops liquid crystal mixtures, organic light-emitting diodes (OLED) materials and cosmetic active ingredients. Merck also provides a wide range of products including lab water systems, gene editing tools, cell lines, antibodies and end-to-end systems. The company serves healthcare, performance materials and life sciences markets. It has presence in Europe, North America, Asia-Pacific, Latin America and Middle East and Africa. Merck is headquartered in Darmstadt, Hesse, Germany.

Merck KGaA Key Recent Developments

Apr 28,2020 Merck signs Covid-19 research alliance with ISB
Apr 21,2020 Merck broadens patient support and assistance programs as part of overall COVID-19 relief efforts
Apr 17,2020 Merck is supporting Darmstadt in the Covid-19 crisis
Mar 27,2020 Novartis partners with life sciences companies to fight Covid-19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Merck KGaA – Key Facts
Merck KGaA – Key Employees
Merck KGaA – Key Employee Biographies
Merck KGaA – Major Products and Services
Merck KGaA – History
Merck KGaA – Company Statement
Merck KGaA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Merck KGaA – Business Description
Business Segment: Healthcare
Overview
Performance
Business Segment: Life Science
Overview
Performance
Business Segment: Performance Materials
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Middle East and Africa (MEA)
Performance
Geographical Segment: North America
Performance
R&D Overview
Merck KGaA – Corporate Strategy
Merck KGaA – SWOT Analysis
SWOT Analysis – Overview
Merck KGaA – Strengths
Merck KGaA – Weaknesses
Merck KGaA – Opportunities
Merck KGaA – Threats
Merck KGaA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Merck KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2020: Merck signs Covid-19 research alliance with ISB
Apr 21, 2020: Merck broadens patient support and assistance programs as part of overall COVID-19 relief efforts
Apr 17, 2020: Merck is supporting Darmstadt in the Covid-19 crisis
Mar 27, 2020: Novartis partners with life sciences companies to fight Covid-19
Mar 26, 2020: Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
Mar 05, 2020: Physiomics awarded further contract by Merck
Mar 03, 2020: Merck’s new Lanexo system to improve scientists productivity in the lab
Feb 27, 2020: Merck and AMCM / EOS Cooperate in 3D Printing of Tablets
Feb 06, 2020: Merck plans spinoff to focus on core areas to achieve faster growth
Jan 28, 2020: Merck to build $275m biotech development plant in Switzerland
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Merck KGaA, Key Facts
Merck KGaA, Key Employees
Merck KGaA, Key Employee Biographies
Merck KGaA, Major Products and Services
Merck KGaA, History
Merck KGaA, Subsidiaries
Merck KGaA, Key Competitors
Merck KGaA, Ratios based on current share price
Merck KGaA, Annual Ratios
Merck KGaA, Annual Ratios (Cont...1)
Merck KGaA, Annual Ratios (Cont...2)
Merck KGaA, Interim Ratios
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Merck KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Merck KGaA, Performance Chart (2015 - 2019)
Merck KGaA, Ratio Charts
Merck KGaA, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Merck KGaA, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Merck KGaA (MRK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ivoclar Vivadent AG:医療機器:M&Aディール及び事業提携情報
    Summary Ivoclar Vivadent AG (Ivoclar Vivadent) is an international dental products providing company. It manufactures material systems for high quality dental applications. The company’s products include impression materials, adhesives, temporary materials, restorative materials, all-ceramics, lutin …
  • eBay Korea Co., Ltd.:企業の戦略的SWOT分析
    eBay Korea Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • MenoGeniX Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MenoGeniX Inc (MenoGeniX) is a biopharmaceutical company that develops treatment for menopausal women and cancer patients. The company provides pipeline products portfolio such as MNGX-100, is under Phase 1b human clinical trial. Its therapeutic agents are developed for new indications such …
  • Exxon Mobil Corp (XOM):電力:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • Downer EDI Ltd (DOW)-エネルギー分野:企業M&A・提携分析
    Summary Downer EDI Limited (Downer) is a diversified services company. The company offers wide range of services such as transport infrastructure, engineering, utility, construction, and maintenance., It also provides mining services such as open-cut mining, crushing, underground mining operations, …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company offers banking, insurance companies, public institutions, healthcare, telecommunication, utilities, ERP solutions, IT infrastructure and others. Its IT infrastructure solutions include …
  • Ocwen Financial Corporation:企業のM&A・事業提携・投資動向
    Ocwen Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ocwen Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Aeroport Anapa OAO:戦略・SWOT・企業財務分析
    Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa OAO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma), a subsidiary of Luye Life Sciences Group Ltd is a drug development company that discovers, manufactures, and commercializes novel formulations, generic drugs, and pharmaceutical products. The company offers its products in the form of tablets, formulation …
  • Guangzhou Wondfo Biotech Co Ltd (300482):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Gemdale Corporation:企業の戦略・SWOT・財務分析
    Gemdale Corporation - Strategy, SWOT and Corporate Finance Report Summary Gemdale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Monsanto Co (MON):企業の財務・戦略的SWOT分析
    Monsanto Co (MON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cyanotech Corp:企業の戦略・SWOT・財務分析
    Cyanotech Corp - Strategy, SWOT and Corporate Finance Report Summary Cyanotech Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Land and Houses Bank PCL:電力:M&Aディール及び事業提携情報
    Summary Land and Houses Bank PCL (Land and Houses Bank), a subsidiary of Thailand based LH Financial Group Public Company Ltd, is a bank that offers personal banking and business banking products and services. The company’s products include savings account, current account, tax-free account, fixed a …
  • Intersurgical Ltd.:企業の戦略的SWOT分析
    Intersurgical Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TCR (London) Ltd :企業の戦略・SWOT・財務情報
    TCR (London) Ltd - Strategy, SWOT and Corporate Finance Report Summary TCR (London) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Lanco Infratech Ltd:発電所・企業SWOT分析
    Lanco Infratech Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆